Report post

What does Akba stand for?

Mar. 28, 2024 5:42 AM ET Akebia Therapeutics, Inc. (AKBA) Stock, CSLLY Stock By: Preeti Singh, SA News Editor 14 Comments

Why did Akebia Therapeutics (Akba) stock surge over 25% premarket?

Akebia Therapeutics ( NASDAQ: AKBA) shares surged over 25% premarket on Thursday after the U.S. Food and Drug Administration (FDA) approved its Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis for at least three months.

What did Akebia Therapeutics (Akba) do in the first quarter?

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today reported financial results for the first quarter ended March 31, 2024.

The World's Leading Crypto Trading Platform

Get my welcome gifts